Big data analysis of outcomes in non-small cell lung cancer at a regional cancer institute with a coordinated precision medicine program. Interplatform and cross-cohort meta-analysis of tumor ...

While researchers work to improve lobular breast cancer screening, innovative treatments are improving outcomes for patients with the condition, which is diagnosed in more than 40,000 Americans each ...

Sichun Yang, PhD, a member of Case CCC's Molecular Oncology Program, and Alberto Montero, MD, a Developmental Therapeutics Program member, are looking for patient advocates for a follow-up study to ...

NCCN Guidelines® recommend FES PET for systemic staging in certain patients with invasive lobular cancer (ILC), which could facilitate greater diagnostic accuracy, earlier interventions, better ...

Lobular breast cancer patients gathered at Fred Hutch Cancer Center last week for a two-hour program featuring patient stories, epidemiological findings and new developments in screening and clinical ...

MSK created this program because we’re experts in treating this type of cancer. Lobular breast cancer is very different from invasive ductal carcinoma, the most common type of breast cancer. It’s ...

Dr. Schwartz answers the question: 'Difference between in situ breast cancers?' — -- Question: What is the difference between ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS)?

TUESDAY, Oct. 14, 2025 (HealthDay News) -- The incidence rates for invasive lobular carcinoma (ILC) increased from 2012 to 2021 for all racial and ethnic groups, according to a study published online ...

Artificial intelligence is making its mark on the future of cancer care. One of the newest applications for the technology is pinpointing hard-to-detect breast cancer. Researchers at Ohio State ...